Therapeutic inadequacy in spite of bioequivalency on replacing Fluctine with Fluocim

Swiss Med Wkly. 2001 Feb 10;131(5-6):84. doi: 10.4414/smw.2001.09678.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antidepressive Agents, Second-Generation / pharmacokinetics*
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Cost Savings
  • Female
  • Fluoxetine / pharmacokinetics*
  • Fluoxetine / therapeutic use
  • Humans
  • Middle Aged
  • Therapeutic Equivalency
  • Treatment Failure

Substances

  • Antidepressive Agents, Second-Generation
  • Fluoxetine